申请人:Hoffmann-La Roche Inc.
公开号:US04464300A1
公开(公告)日:1984-08-07
There are presented benzazepines of the formula ##STR1## wherein either R.sup.1 is hydrogen, lower alkyl, 4-pyridyl or the group --(CH.sub.2).sub.n --NR.sup.6 R.sup.7 and R.sup.2 and R.sup.3 together are an additional bond or R.sup.1 and R.sup.2 together are the oxo group and R.sup.3 is hydrogen or lower alkyl, R.sup.4 is phenyl, o-halophenyl or 2-pyridyl, R.sup.5 is halogen or nitro and either R.sup.6 is hydrogen or lower alkyl and R.sup.7 is hydrogen, lower alkyl, lower alkenyl or lower alkynyl or R.sup.6 and R.sup.7 together with the nitrogen atom are 4-(lower alkyl)-1-piperazinyl or 4-morpholinyl and n is the number 0 or 1, and their pharmaceutically acceptable acid additions salts. The compounds possess interesting psychotropic properties, i.e., pronounced anxiolytic properties have been established in the case of certain representative members of this class of substance.
提供了以下结构式的苯并氮杂环化合物##STR1##,其中R.sup.1为氢、较低的烷基、4-吡啶基或基团--(CH.sub.2).sub.n --NR.sup.6 R.sup.7,且R.sup.2和R.sup.3一起为额外的键或R.sup.1和R.sup.2一起为氧代基团,R.sup.3为氢或较低的烷基,R.sup.4为苯基、o-卤苯基或2-吡啶基,R.sup.5为卤素或硝基,且R.sup.6为氢或较低的烷基,R.sup.7为氢、较低的烷基、较低的烯基或较低的炔基,或R.sup.6和R.sup.7与氮原子一起为4-(较低的烷基)-1-哌嗪基或4-吗啉基,n为数字0或1,以及它们的药学上可接受的酸盐。这些化合物具有有趣的精神药理特性,即在这类物质的某些代表性成员中已经确定了明显的抗焦虑特性。